Brief: Asit Biotech announces grant from European Patent Office related to ASIT+ allergy immunotherapy product candidates

European Medical Solutions SA

23/11/2017 06:02

Nov 23 (Reuters) - ASIT BIOTECH SA  ASIT.BR :  
    * EUROPEAN PATENT OFFICE GRANTS CO SECOND PATENT RELATED TO 
ACTIVE INGREDIENTS USED IN ASIT+ ALLERGY IMMUNOTHERAPY PRODUCT 
CANDIDATES 
    * GRANT WILL BE EFFECTIVE FROM NOVEMBER 29, 2017 UNTIL JUNE 
15, 
2032 WITH A POSSIBLE EXTENSION OF 5 YEARS 
    * PATENT PROSECUTIONS FOR GRANT IN CANADA, JAPAN, USA, 
CHINA, 
INDIA AND BRAZIL ARE ONGOING 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nBw1x1p6Va 
Further company coverage:  ASIT.BR  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))